The embryonic Octamer factor 3/4 displays distinct DNA binding specificity from those of other Octamer factors

Biochemical and Biophysical Research Communications

Volumn 302, Issue 3, 2003, Pages 581-586

  Nishimoto, Masazumi ^a   Miyagi, Satoru ^a   Katayanagi, Tomoko ^a   Tomioka, Mizuho ^a   Muramatsu, Masami ^a   Okuda, Akihiko ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Embryonic stem cell; Mammalian early embryogenesis Octamer factors; Oct 3 4; Regulatory element

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR OCT3 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING KINETICS; BINDING SITE; DNA BINDING; EMBRYO; EMBRYO CELL; EMBRYO DEVELOPMENT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; REGULATORY SEQUENCE; STEM CELL; TRANSCRIPTION INITIATION;

MAMMALIA;

EID: 0037436815     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00218-3     Document Type: Article

References (19)

1. Hogan B., Beddington R., Constantini F., Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual. second ed. 1994;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
2. Gilbert S.F. Developmental Biology. third ed. 1991;Sinauer Associates, Sunderland, MA.
3. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA. 78:1981;7634-7638.
4. Okamoto K., Okazawa H., Okuda A., Saka M., Muramatsu M., Hamada H. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell. 60:1990;461-472.
5. Rosner M.H., Vigano M.A., Ozato K., Thimmons P.M., Poirier F., Rigby P.W.J., Staudt L.M. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature. 345:1990;686-692.
6. Scholer H.R., Ruppert S., Suzuki N., Chowdhury K., Gruss P. New type of POU domain in germ line-specific protein Oct-4. Nature. 344:1990;435-439.
7. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chamber J., Scholer H.R., Smith A.G. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct-4. Cell. 95:1998;379-391.
8. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24:2000;372-376.
9. Okuda A., Fukushima A., Nishimoto M., Yamagishi T., Orimo A., Nabeshima Y., Kuro-o M., Nabeshima Y., Boon K., Keaveney M., Stunnenberg H.G., Muramatsu M. UTF1, a novel transcriptional coactivator expressed in pluripotent embryonc stem cells and extra-embryonic cells. EMBO J. 17:1998;2019-2032.
10. Nishimoto M., Fukushima A., Okuda A., Muramatsu M. The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol. Cell. Biol. 19:1999;5453-5465.
11. Tomioka M., Nishimoto M., Miyagi S., Katayanagi T., Fukui N., Niwa H., Muramatsu M., Okuda A. Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res. 30:2002;3202-3213.
12. Botquin V., Hess H., Fuhrmann G., Anastassiandis C., Gross M.K., Vriend G., Scholer H.R. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev. 12:1998;2073-2090.
13. Hosler B.A., LaRosa G.J., Grippo J.F., Gudas L.J. Expression of REX-1, a gene containing zinc finger motifs is rapidly reduced by retinoic acid in F9 teratocarcinoma cells. Mol. Cell. Biol. 9:1989;5629-5635.
14. Ben-Shushan E., Thompson J.R., Gudas L.J., Bergman Y. Rex-1, a gene encoding a transcriptional factor expressed in the early embryo, regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol. Cell. Biol. 18:1998;1866-1878.
15. Yuan H., Corbi N., Basilico C., Dailey L. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 9:1995;2635-2645.
16. Ambrosetti D.C., Basilico C., Dailey L. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol. Cell. Biol. 17:1997;6321-6329.
17. Ambrosetti D.C., Scholer H.R., Dailey L., Basilico C. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. J. Biol. Chem. 275:2000;23387-23397.
18. Dailey L., Basilico C. Coevolution of HMG domains and homeo-domains and the generation of transcriptional regulation by Sox/POU complexes. J. Cell. Physiol. 186:2001;3150328.
19. Niwa H., Masui S., Chambers I., Smith A.G., Miyazaki J. Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol. Cell. Biol. 22:2002;1526-1536.